甲状腺乳头状癌中AR、ER与TSHR表达水平关系的临床研究

doi:10.3969/j.issn.10073205.2019.03.013

摘要/Abstract

摘要： ［摘要］〓
〖HTH〗目的〖HTSS〗〖KG*2〗分析雄激素受体(androgen receptor，AR)、雌激素受体(estrogen receptor，ER)和促甲状腺激素受体(thyroidstimulating hormone receptor，TSHR)在甲状腺乳头状癌(papillary thyroid carcinoma，PTC)组织中的表达及相关性，并探讨三者在PTC中的作用及预后判断。
〖HTH〗方法〖HTSS〗〖KG*2〗采用免疫组织化学方法对197例PTC及50例癌旁正常组织和50例甲状腺良性肿瘤组织中AR、ER与TSHR的表达进行检测。
〖HTH〗结果〖HTSS〗〖KG*2〗PTC组织、PTC旁组织中ER、TSHR阳性表达显著高于良性甲状腺肿瘤组织，AR阳性表达显著低于良性甲状腺肿瘤组织,差异均有统计学意义(P＜005）。女性ER、TSHR和AR阳性表达高于男性，年龄＜45岁者ER阳性表达高于≥45岁者，有包膜浸润者ER、TSHR阳性表达高于无包膜浸润者，肿瘤直径≥4 cm 者ER、TSHR阳性表达高于肿瘤直径＜4 cm者，有淋巴结转移者ER、TSHR阳性表达高于无淋巴结转移者，肿瘤分期Ⅲ~Ⅳ者ER、TSHR阳性表达高于肿瘤分期Ⅰ~Ⅱ者，差异均有统计学意义（P＜005）。ER与TSHR在PTC组织中的蛋白表达水平呈正相关（rs=0575，P＜005）；ER与AR、AR与TSHR在PTC组织中的蛋白表达水平呈负相关（rs=-0.160，P＜005；rs=-0.186，P＜005），但相关性较弱。
〖HTH〗结论〖HTSS〗〖KG*2〗ER、TSHR二者联合检测有望成为诊断PTC侵袭转移的重要指标。AR可能是一个保护性的因素，PTC中AR高表达提示预后较好。

关键词: 甲状腺肿瘤, 受体, 雄激素, 受体, 雌激素

Abstract: ［Abstract］ Objective〖HTSS〗〓To analyze expression and correlation of androgen receptor(androgen receptor, AR) , estrogen receptors(estrogen receptor, ER) and thyroid stimulating hormone receptor(thyroidstimulating hormone receptor, TSHR) in thyroid papillary carcinoma(papillary thyroid carcinoma, PTC) expression and correlation of organization, The roles of the three factors in PTC and prognosis were also discussed.
〖HTH〗〖WTHZ〗Methods〖HTSS〗〓The expressions of AR, ER and TSHR in 197 cases of PTC, 50 cases of paracancer normal tissues and 50 cases of thyroid benign tumors were detected by immunohistochemistry.
〖HTH〗〖WTHZ〗Results〖HTSS〗〓The positive expression of ER and TSHR in PTC tissues and paraPTC tissues were significantly higher than those in benign thyroid neoplasms, and the positive expression of AR was significantly lower than that in benign thyroid neoplasms（P＜005）. The positive rate of ER, TSHR and AR expression in female was higher than that in male. The positive rate of ER expression in patients aged＜45 years was higher than that in patients aged≥45 years. The positive expression rates of ER and TSHR in patients with capsule infiltration were higher than those without. The positive rates of ER and TSHR expression in patients with tumor diameter 4 cm were higher than those with tumor diameter<4 cm. The positive rates of ER and TSHR expression in patients with lymph node metastasis were higher than those without lymph node metastasis. Tumor staging Ⅲ-Ⅳ ER and TSHR expression positive rate was higher than the tumor staging Ⅰ-Ⅱ, the differences were statistically significant(P＜005). There was a positive correlation between ER and TSHR protein expression in PTC tissues(rs=0575, P＜005), and a negative correlation between ER and AR, AR and TSHR protein expression in PTC tissues(rs=-0.160, P＜005, rs=-0.186, P＜005), but the correlation was weak.
〖HTH〗〖WTHZ〗Conclusion〖HTSS〗〓Combined detection of ER and TSHR is expected to be an important indicator for the diagnosis of PTC invasion and metastasis. AR may be a protective factor, and high expression of AR in PTC indicates a better prognosis.

Key words: thyroid , neoplasms； receptors, androgen； receptors, estrogen

曾剑锋，余外市，周志平，邱成志，黄种心. 甲状腺乳头状癌中AR、ER与TSHR表达水平关系的临床研究[J]. 河北医科大学学报, doi: 10.3969/j.issn.10073205.2019.03.013.

ZENG Jianfeng, YU Waishi, ZHOU Zhiping, QIU Chengzhi, HUANG Zhongxin. Clinical research on the relationship between AR, ER and TSHR expression in papillary thyroid carcinoma#br#[J]. Journal of Hebei Medical University, doi: 10.3969/j.issn.10073205.2019.03.013.

[1]	康丽娟, 李盼, 耿丽颖, 孟琦. 补体激活3a受体检测评估大剂量阿托伐他汀联合双联抗血小板治疗急性脑梗死的效果研究 [J]. 河北医科大学学报, 2023, 44(9): 1011-1016.
[2]	梁新科, 王鹏飞, 江夏芸, 刘阳, 赵瑞力. 纳米炭结合术中触诊用于T1~T2期cN0单灶甲状腺乳头状癌选择性中央区淋巴结清扫的可行性分析 [J]. 河北医科大学学报, 2023, 44(8): 910-914.
[3]	文勃, 李玲, 冯杨, 罗丽. 血乳酸、CCSP、IL-22R在小儿肺炎中的表达及临床意义 [J]. 河北医科大学学报, 2023, 44(7): 840-843,865.
[4]	赖盛联, 毛敏, 黄林. CEACAM6、miR-146b、S100A6在甲状腺癌中的表达及意义分析 [J]. 河北医科大学学报, 2023, 44(5): 531-535,552.
[5]	吴苏敏, 周欣, 王丽波. 血清CMKLR1、FSTL1水平与糖尿病视网膜病变严重程度相关性 [J]. 河北医科大学学报, 2023, 44(2): 189-193,213.
[6]	郝雅丽, 白小双（综述）, 康山（审校）. GRHL2与雌激素相关性肿瘤发展关系的研究进展 [J]. 河北医科大学学报, 2023, 44(11): 1354-1359.
[7]	凌琬茗, 刘岩, 谷红霞, 赵瑞雪, 韩志敏. CYP1A1、TSLPR、CCR3在小儿特应性皮炎中的表达及与临床特征相关性研究 [J]. 河北医科大学学报, 2022, 43(9): 1052-1056,1061.
[8]	刘彦权（综述）, 陈玉婷, 唐焕文（审校）. CXC趋化因子受体家族与恶性肿瘤相关性研究 [J]. 河北医科大学学报, 2022, 43(7): 853-859.
[9]	王瑞, 张玲叶, 杜艳华. Sigma-1受体激动剂PRE-084对大鼠心肌缺血再灌注损伤的保护作用[J]. 河北医科大学学报, 2022, 43(4): 377-380.
[10]	张雪鹤. 甲状腺超声联合血清Tg、TgAb对甲状腺癌术后复发诊断中的作用[J]. 河北医科大学学报, 2022, 43(4): 455-459,465.
[11]	韦琴, 史卫卫, 杨语嫣, 路笑颖, 曹亚景, 崔泽. 维生素D受体基因多态性与代谢综合征相关性的Meta分析[J]. 河北医科大学学报, 2022, 43(3): 280-285.
[12]	张鑫, 肖妮. MCM7在甲状腺乳头状癌组织中的表达及与survivin和P27蛋白的关系分析[J]. 河北医科大学学报, 2022, 43(3): 326-330.
[13]	赵国杰, 杨宏伟, 赵鹏飞. HSF1、sMR、miR-758-3p在肝癌患者中的表达及与临床病理特征的关系 [J]. 河北医科大学学报, 2022, 43(11): 1267-1271.
[14]	王婷婷, 赵一涵（综述）, 于杰 , 张洪珍（审校）. CCR8+Tregs：三阴性乳腺癌潜在治疗靶点 [J]. 河北医科大学学报, 2022, 43(10): 1220-1223.
[15]	邵俊国, 黄秀香, 叶迎宾. 甲状腺乳头状癌患者血清甲状腺激素指标结果的相关性分析[J]. 河北医科大学学报, 2022, 43(1): 87-90.

甲状腺乳头状癌中AR、ER与TSHR表达水平关系的临床研究

Clinical research on the relationship between AR, ER and TSHR expression in papillary thyroid carcinoma#br#

HTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价